PROK
Price:
$1.56
Market Cap:
$451.89M
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.[Read more]
Industry
Biotechnology
IPO Date
2021-06-30
Stock Exchange
NASDAQ
Ticker
PROK
According to ProKidney Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 244.06M. This represents a change of 573.91% compared to the average of 36.22M of the last 4 quarters.
The mean historical Enterprise Value of ProKidney Corp. over the last ten years is 895.45M. The current 244.06M Enterprise Value has changed 2.63% with respect to the historical average. Over the past ten years (40 quarters), PROK's Enterprise Value was at its highest in in the June 2022 quarter at 627.44M. The Enterprise Value was at its lowest in in the December 2022 quarter at -65687015.34.
Average
895.45M
Median
779.68M
Minimum
-65687015.34
Maximum
1.88B
Discovering the peaks and valleys of ProKidney Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 141.44%
Maximum Annual Enterprise Value = 1.88B
Minimum Annual Increase = -181.62%
Minimum Annual Enterprise Value = -65687015.34
Year | Enterprise Value | Change |
---|---|---|
2023 | 53.61M | -181.62% |
2022 | -65687015.34 | -103.60% |
2021 | 1.83B | -2.94% |
2020 | 1.88B | 141.44% |
The current Enterprise Value of ProKidney Corp. (PROK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
605.02M
5-year avg
895.45M
10-year avg
895.45M
ProKidney Corp.’s Enterprise Value is less than Relay Therapeutics, Inc. (867.37M), less than Stoke Therapeutics, Inc. (501.96M), less than Pliant Therapeutics, Inc. (860.85M), greater than Black Diamond Therapeutics, Inc. (159.92M), less than Arvinas, Inc. (1.76B), less than Arcellx, Inc. (4.62B), greater than Ventyx Biosciences, Inc. (122.28M), less than Immunocore Holdings plc (1.53B), less than Vaxcyte, Inc. (12.48B), less than DICE Therapeutics, Inc. (2.21B), less than Third Harmonic Bio, Inc. (245.75M), greater than PMV Pharmaceuticals, Inc. (48.13M), less than Edgewise Therapeutics, Inc. (3.19B), greater than Enochian Biosciences, Inc. (102.45M), less than Revolution Medicines, Inc. (9.07B), less than Kura Oncology, Inc. (1.34B), less than Protagonist Therapeutics, Inc. (2.41B), less than Merus N.V. (3.08B), less than Replimune Group, Inc. (745.52M), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than Monte Rosa Therapeutics, Inc. (478.04M), less than Erasca, Inc. (691.95M), less than Lyell Immunopharma, Inc. (251.92M),
Company | Enterprise Value | Market cap |
---|---|---|
867.37M | $950.40M | |
501.96M | $689.69M | |
860.85M | $881.01M | |
159.92M | $168.95M | |
1.76B | $1.84B | |
4.62B | $4.65B | |
122.28M | $151.94M | |
1.53B | $1.56B | |
12.48B | $12.97B | |
2.21B | $2.27B | |
245.75M | $497.49M | |
48.13M | $84.49M | |
3.19B | $3.23B | |
102.45M | $45.38M | |
9.07B | $9.33B | |
1.34B | $1.36B | |
2.41B | $2.75B | |
3.08B | $3.51B | |
745.52M | $821.22M | |
8.24B | $8.19B | |
478.04M | $542.54M | |
691.95M | $810.79M | |
251.92M | $325.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProKidney Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProKidney Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ProKidney Corp.'s Enterprise Value?
What is the highest Enterprise Value for ProKidney Corp. (PROK)?
What is the 3-year average Enterprise Value for ProKidney Corp. (PROK)?
What is the 5-year average Enterprise Value for ProKidney Corp. (PROK)?
How does the current Enterprise Value for ProKidney Corp. (PROK) compare to its historical average?